文献清单:“糖尿病新型治疗技术”方向 | MDPI Diabetology

  期刊名:Diabetology

  期刊主页:https://www.mdpi.com/journal/diabetology

  导语:

  糖尿病,作为一种以慢性高血糖为特征的代谢性疾病,严重威胁全球健康,其治疗技术的革新至关重要。传统治疗手段在控糖方面存在一定局限,难以从根本上扭转糖尿病的病理进程。因此,新型治疗技术成为科研与临床关注焦点。该文献清单梳理了多篇聚焦糖尿病新型治疗技术的文献,旨在为相关领域的科研人员、临床医生以及关注糖尿病治疗进展的各界人士,提供全面且深入的研究资料,助力推动糖尿病治疗技术迈向新高度,改善全球糖尿病患者的生活质量与预后。

  正文部分:

  1. Managing Hospitalized Patients Taking SGLT2 Inhibitors: Reducing the Risk of Euglycemic Diabetic Ketoacidosis

  住院患者 SGLT2 抑制剂用药管理:降低正常血糖性糖尿病酮症酸中毒风险

  https://www.mdpi.com/2673-4540/4/1/10

  2. Advanced Technology (Continuous Glucose Monitoring and Advanced Hybrid Closed-Loop Systems) in Diabetes from the Perspective of Gender Differences

  糖尿病领域先进技术(连续血糖监测与高级混合闭环系统)的性别差异视角研究

  https://www.mdpi.com/2673-4540/4/4/45

  3. Melanocortins and Their Potential for the Treatment, Prevention and Amelioration of Complications of Diabetes

  黑素皮质素在糖尿病治疗、预防及并发症改善中的潜力

  https://www.mdpi.com/2673-4540/5/1/6

  4. Exosome-Derived microRNAs: Bridging the Gap Between Obesity and Type 2 Diabetes in Diagnosis and Treatment

  外泌体衍生微小 RNA:衔接肥胖与 2 型糖尿病诊疗的桥梁

  https://www.mdpi.com/2673-4540/5/7/52

  5. Does the Efficacy of Semaglutide Treatment Differ between Low-Risk and High-Risk Subgroups of Patients with Type 2 Diabetes and Obesity Based on SCORE2, SCORE2-Diabetes, and ASCVD Calculations?

  基于 SCORE2、SCORE2 - 糖尿病及 ASCVD 评分的 2 型糖尿病合并肥胖患者中,司美格鲁肽疗效在高低风险亚组间的差异?

  https://www.mdpi.com/2673-4540/5/1/3

  6. Exploration of Foundational Models for Blood Glucose Forecasting in Type-1 Diabetes Pediatric Patients

  1 型糖尿病儿童患者血糖预测基础模型的探索

  https://www.mdpi.com/2673-4540/5/6/42

  7. Impact of Hypoglycemia on Glucose Variability over Time for Individuals with Open-Source Automated Insulin Delivery Systems

  开源自动胰岛素输注系统使用者中,低血糖对长期血糖变异性的影响

  https://www.mdpi.com/2673-4540/5/5/38

  8. Evaluation of Insulin Secretion and Continuous Glucose Monitoring in Patients with Cystic Fibrosis After Initiation of Transmembrane Conductance Regulator Modulator: A 52-Week Prospective Study

  跨膜传导调节因子调节剂启动后,囊性纤维化患者胰岛素分泌及连续血糖监测的 52 周前瞻性评估

  https://www.mdpi.com/2673-4540/5/6/40

Diabetology 期刊介绍

  主编:Prof. Dr. Peter Clifton, University of South Australia, , Australia

  期刊主题涵盖糖尿病的流行病学、病因学、病理生理学、发病机制、临床管理、并发症、预防策略,以及疾病相关的分子、生化与生理机制等多个研究领域。目前已被 SCIE(Web of Science)、Scopus 等国际权威数据库收录。

  2024 Impact Factor

  2. 2

  2024 CiteScore

  3. 7

  Time to First Decision

  26. 3 Days

  Acceptance to Publication

  5. 8 Days

  欢迎浏览 Diabetology 期刊高引文章:

  https://www.mdpi.com/journal/diabetology/most_cited